TG Therapeutics | TGTX - Cost Of Sales



TG Therapeutics reported $18.94M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AbbVie USD 4.35B 344M Jun/2025
Alaunos Therapeutics 0 18K Sep/2024
Amgen USD 3.01B 406M Jun/2025
Ardelyx USD 14.82M 3.44M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Biogen USD 605M 24.3M Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Dynavax Technologies USD 14.04M 13.5M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
J&J USD 7.6B 304M Jun/2025
Novartis USD 3.32B 95M Jun/2025
PTC Therapeutics USD 15.48M 2.62M Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
TG Therapeutics USD 18.94M 3.4M Jun/2025
Vertex Pharmaceuticals USD 407.5M 44.5M Jun/2025